HRB 732007:
STRATEC SE,
Birkenfeld, Gewerbestraße 37, 75217 Birkenfeld. The Annual General Meeting of 8 June 2020 approved the amendment of the Articles of Association in Sections 4 (share capital) and 14 (place and convocation). The authorisation of the Executive Board by resolution of the Annual General Meeting of the
STRATEC Biomedical AG of 22 May 2015 to increase the share capital of the company by up to a total of EUR 5,500,000.00 (Authorised Capital 2015/I) has expired due to the expiry of the year. By resolution of the Annual General Meeting of 8 June 2020, the Management Board is authorised, with the approval of the Supervisory Board, to increase the company's share capital once or several times by up to a total of EUR 2,400,000.00 against cash and/or in-interest deposits by the approval of the Supervisory Board. Shareholders' subscription rights may be excluded (Authorised Capital 2020/I). The Annual General Meeting of 8 June 2020 abolished the conditional capital (Conditional Capital V (2009)) decided on 20 May 2009. The Annual General Meeting of 8 June 2020 repealed the conditional capital (Conditional Capital VII (2015)) decided on 22 May 2015. The Annual General Meeting of 8 June 2020 approved the conditional increase in the share capital by up to a total of EUR 800,000.00 (Conditional Capital IX/2020).